Table 2.
Total | OW | PCOS | ||||
---|---|---|---|---|---|---|
r | P value | r | P value | r | P value | |
Age (y) | 0.021 | 0.798 | 0.206 | 0.057 | 0.119 | 0.308 |
BMI (kg/m2) | 0.104 | 0.202 | -0.077 | 0.481 | -0.083 | 0.479 |
WHR | 0.162 | 0.047 | 0.119 | 0.275 | 0.075 | 0.524 |
FBG (mmol/L) | 0.351 | <0.0001 | 0.379 | < 0.001 | 0.464 | <0.0001 |
FINS (mU/mL) | -0.021 | 0.799 | -0.207 | 0.056 | -0.112 | 0.337 |
HbA1c (%) | 0.034 | 0.679 | 0.023 | 0.834 | 0.281 | 0.015 |
HOMAIR | 0.067 | 0.412 | -0.090 | 0.412 | 0.040 | 0.733 |
HOMA-β | -0.211 | 0.009 | -0.371 | < 0.001 | -0.327 | 0.004 |
TG (mmol/L) | 0.101 | 0.217 | 0.017 | 0.874 | 0.155 | 0.185 |
TC (mmol/L) | 0.178 | 0.029 | 0.228 | 0.035 | 0.184 | 0.115 |
HDL-C (mmol/L) | 0.034 | 0.680 | 0.123 | 0.258 | -0.036 | 0.761 |
LDL-C (mmol/L) | 0.033 | 0.685 | 0.030 | 0.787 | 0.109 | 0.352 |
ALT (IU/L) | 0.071 | 0.386 | -0.048 | 0.664 | 0.082 | 0.484 |
AST (IU/L) | 0.070 | 0.389 | 0.027 | 0.805 | 0.080 | 0.494 |
γ-GGT (IU/L) | 0.124 | 0.128 | -0.007 | 0.948 | 0.312 | 0.006 |
UA (μmol/L) | -0.033 | 0.687 | -0.277 | 0.010 | -0.038 | 0.743 |
Creatinine (μmol/L) | -0.099 | 0.224 | -0.152 | 0.162 | 0.033 | 0.779 |
BUN (mmol/L) | -0.095 | 0.245 | 0.029 | 0.788 | -0.026 | 0.823 |
Testosterone (nmol/L) | -0.053 | 0.526 | -0.234 | 0.030 | -0.054 | 0.643 |
LH (mIU/L) | -0.106 | 0.210 | -0.109 | 0.318 | -0.066 | 0.572 |
FSH (mIU/L) | 0.132 | 0.117 | 0.145 | 0.182 | 0.155 | 0.185 |
LH/FSH | -0.172 | 0.040 | -0.243 | 0.024 | -0.082 | 0.483 |
Estradiol (pg/mL) | 0.117 | 0.163 | 0.345 | 0.001 | 0.033 | 0.781 |
Progesterone (ng/mL) | 0.125 | 0.137 | 0.268 | 0.013 | 0.022 | 0.850 |
PRL (ng/mL) | -0.013 | 0.873 | -0.028 | 0.799 | -0.020 | 0.867 |
WBC (∗10^9/L) | -0.048 | 0.557 | -0.129 | 0.239 | 0.038 | 0.746 |
The correlations were determined by the Spearman analysis. Total: all participants; OW: overweight participants; PCOS: participants with polycystic ovary syndrome.